购物车
- 全部删除
- 您的购物车当前为空
Anti-VCAM-1 Antibody-HRP (8I177) 是一种 HRP-conjugated Mouse 抗体,靶向 VCAM-1。Anti-VCAM-1 Antibody-HRP (8I177) 可用于 ELISA。
Anti-VCAM-1 Antibody-HRP (8I177) 是一种 HRP-conjugated Mouse 抗体,靶向 VCAM-1。Anti-VCAM-1 Antibody-HRP (8I177) 可用于 ELISA。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 μg | ¥ 2,495 | 5日内发货 |
产品描述 | Anti-VCAM-1 Antibody-HRP (8I177) is a HRP-conjugated Mouse antibody targeting VCAM-1. Anti-VCAM-1 Antibody-HRP (8I177) can be used in ELISA. |
别名 | VCAM-1, vascular cell adhesion molecule 1, INCAM-100, CD106 |
Ig Type | Monoclonal Mouse IgG1 |
克隆号 | 8I177 |
交叉反应 | Human |
应用 | ELISA |
推荐剂量 | ELISA: 0.1-1 μg/ml |
抗体种类 | Monoclonal |
宿主来源 | Mouse |
构建方式 | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human VCAM1/VCAM-1/CD106 (rh VCAM1/VCAM-1/CD106; NP_001069.1Met1-Pro697). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography and conjugated with horseradish-peroxidase (HRP). |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | Vascular cell adhesion molecule 1 (VCAM-1), also known as CD106, is a cell surface sialoglycoprotein belonging to the immunoglobulin superfamily. Two forms of VCAM-1 with either six or seven extracellular Ig-like domains are generated by alternative splicing, with the longer form predominant. VCAM-1 is an endothelial ligand for very late antigen-4 (VLA-4) and α4ß7 integrin expressed on leukocytes, and thus mediates leukocyte-endothelial cell adhesion and signal transduction. VCAM-1 expression is induced on endothelial cells during inflammatory bowel disease, atherosclerosis, allograft rejection, infection, and asthmatic responses. During these responses, VCAM-1 forms a scaffold for leukocyte migration. VCAM-1 also activates signals within endothelial cells resulting in the opening of an "endothelial cell gate" through which leukocytes migrate. VCAM-1 has been identified as a potential anti-inflammatory therapeutic target, the hypothesis being that reduced expression of VCAM-1 will slow the development of atherosclerosis. In addition, VCAM-1-activated signals in endothelial cells are regulated by cytokines indicating that it is important to consider both endothelial cell adhesion molecule expression and function during inflammatory processes.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
偶联 | HRP |
其他可选修饰符 | Unconjugated |
可提供抗体种类 | 2 |
免疫原 | Recombinant Human VCAM1/VCAM-1/CD106 Protein |
抗原种属 | Human |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. Keep away from direct sunlight. |
运输方式 | Shipping with blue ice. |
评论内容